All Stories

  1. Microplastics accumulate in all major organs of the mediterranean loggerhead sea turtle (Caretta caretta)
  2. Safety Assessment of Graphene‐Based Materials
  3. The key characteristics of cardiotoxicity for the pervasive pollutant phenanthrene
  4. First-in-human controlled inhalation of thin graphene oxide nanosheets to study acute cardiorespiratory responses
  5. Environmental and Health Impacts of Graphene and Other Two-Dimensional Materials: A Graphene Flagship Perspective
  6. Pulmonary Toxicity of Boron Nitride Nanomaterials Is Aspect Ratio Dependent
  7. Lung Persistence, Biodegradation, and Elimination of Graphene‐Based Materials are Predominantly Size‐Dependent and Mediated by Alveolar Phagocytes
  8. 59 First-in-Human Controlled Exposure to Inhaled Graphene Oxide
  9. 73 Evaluating the Risks of Prolonged Exposure to Graphene Oxide on Healthy and Streptococcus Pneumoniae Infected 3D Reconstituted Human Lung Cultures
  10. 61 Evaluation of the Toxicity, Alveolar Cell Accumulation and Clearance of PET and PS Nanoplastics in Mouse Lungs
  11. Correlative radioimaging and mass spectrometry imaging: a powerful combination to study14C-graphene oxidein vivobiodistribution
  12. Lung recovery from DNA damage induced by graphene oxide is dependent on size, dose and inflammation profile
  13. SOC-IV-01 Graphene oxide and hexagonal boron nitride nanosheets do not induce innate immune memory
  14. SOC-III-03 Pulmonary toxicity of graphene based materials is governed by size-dependant biodegradation and clearance in alveolar phagocytes
  15. Hazard assessment of abraded thermoplastic composites reinforced with reduced graphene oxide
  16. Innate but Not Adaptive Immunity Regulates Lung Recovery from Chronic Exposure to Graphene Oxide Nanosheets
  17. Graphene oxide modulates dendritic cell ability to promote T cell activation and cytokine production
  18. Adsorption of P103 Nanoaggregates on Graphene Oxide Nanosheets: Role of Electrostatic Forces in Improving Nanosheet Dispersion
  19. Dynamic interactions and intracellular fate of label-free, thin graphene oxide sheets within mammalian cells: role of lateral sheet size
  20. Intracerebral Injection of Graphene Oxide Nanosheets Mitigates Microglial Activation Without Inducing Acute Neurotoxicity: A Pilot Comparison to Other Nanomaterials
  21. Deep Tissue Translocation of Graphene Oxide Sheets in Human Glioblastoma 3D Spheroids and an Orthotopic Xenograft Model
  22. Nose-to-Brain Translocation and Cerebral Biodegradation of Thin Graphene Oxide Nanosheets
  23. Splenic Capture and In Vivo Intracellular Biodegradation of Biological-Grade Graphene Oxide Sheets
  24. Size-Dependent Pulmonary Impact of Thin Graphene Oxide Sheets in Mice: Toward Safe-by-Design
  25. Graphene oxide nanosheets modulate spinal glutamatergic transmission and modify locomotor behaviour in an in vivo zebrafish model
  26. Biocompatibility Considerations in the Design of Graphene Biomedical Materials
  27. Nanotechnology Characterization Tools for Environment, Health, and Safety
  28. Safety Assessment of Graphene-Based Materials: Focus on Human Health and the Environment
  29. Graphene-based papers as substrates for cell growth: Characterisation and impact on mammalian cells
  30. Immunological impact of graphene oxide sheets in the abdominal cavity is governed by surface reactivity
  31. A blueprint for the synthesis and characterisation of thin graphene oxide with controlled lateral dimensions for biomedicine
  32. A Blueprint for the Synthesis and Characterisation of Thin Graphene Oxide with Controlled Lateral Dimensions for Biomedicine
  33. A Blueprint for the Synthesis and Characterisation of Thin Graphene Oxide with Controlled Lateral Dimensions for Biomedicine
  34. Outstanding Reviewers for Environmental Science: Nano in 2017
  35. Live Imaging of Label-Free Graphene Oxide Reveals Critical Factors Causing Oxidative-Stress-Mediated Cellular Responses
  36. Hypochlorite degrades 2D graphene oxide sheets faster than 1D oxidised carbon nanotubes and nanohorns
  37. Culture Media Critically Influence Graphene Oxide Effects on Plasma Membranes
  38. Direct visualization of carbon nanotube degradation in primary cells by photothermal imaging
  39. Primary microglia maintain their capacity to function despite internalisation and intracellular loading with carbon nanotubes
  40. ‘Science in the city’: bringing nanoscale medicine alive
  41. Gadolinium-functionalised multi-walled carbon nanotubes as a T 1 contrast agent for MRI cell labelling and tracking
  42. Intracellular degradation of chemically functionalized carbon nanotubes using a long-term primary microglial culture model
  43. Microglia Determine Brain Region-Specific Neurotoxic Responses to Chemically Functionalized Carbon Nanotubes
  44. Peptide Nanofiber Complexes with siRNA for Deep Brain Gene Silencing by Stereotactic Neurosurgery
  45. Biodegradation of carbon nanohorns in macrophage cells
  46. The current graphene safety landscape – a literature mining exercise
  47. - Nanomedicine: Ethical Considerations
  48. Generation of induced pluripotent stem cells from virus-free in vivo reprogramming of BALB/c mouse liver cells
  49. The role of p53 in lung macrophages following exposure to a panel of manufactured nanomaterials
  50. In vivo Reprogramming of Adult Somatic Cells to Pluripotency by Overexpression of Yamanaka Factors
  51. Carbon nanotubes in medicine and biology — Safety and toxicology
  52. Hemotoxicity of carbon nanotubes
  53. In Vivo Cell Reprogramming towards Pluripotency by Virus-Free Overexpression of Defined Factors
  54. Design, engineering and structural integrity of electro-responsive carbon nanotube- based hydrogels for pulsatile drug release
  55. Peptide nanofibres as molecular transporters: from self-assembly to in vivo degradation
  56. Intracellular fate of carbon nanotubes inside murine macrophages: pH-dependent detachment of iron catalyst nanoparticles
  57. Safety Considerations for Graphene: Lessons Learnt from Carbon Nanotubes
  58. In vivodegradation of functionalized carbon nanotubes after stereotactic administration in the brain cortex
  59. Critical role of surface chemical modifications induced by length shortening on multi-walled carbon nanotubes-induced toxicity
  60. Therapeutic Applications
  61. Functional motor recovery from brain ischemic insult by carbon nanotube-mediated siRNA silencing
  62. Polyamine functionalized carbon nanotubes: synthesis, characterization, cytotoxicity and siRNA binding
  63. Coating carbon nanotubes with a polystyrene-based polymer protects against pulmonary toxicity
  64. Pectins and pectinases
  65. Adverse Effects of Industrial Multiwalled Carbon Nanotubes on Human Pulmonary Cells
  66. Carbon Nanotubes in Macrophages: Imaging and Chemical Analysis by X-ray Fluorescence Microscopy
  67. Modulatingin vitrobone cell and macrophage behavior by immobilized enzymatically tailored pectins
  68. Enzymatically-tailored pectins differentially influence the morphology, adhesion, cell cycle progression and survival of fibroblasts
  69. Modulation of fibroblast behaviour by enzymatically-tailored pectins: PectiCoat
  70. Heterogeneous accumulation of uranium in the brain of rats
  71. Comparison of the effects of enriched uranium and 137-cesium on the behaviour of rats after chronic exposure
  72. Parental exposure to enriched uranium induced delayed hyperactivity in rat offspring
  73. Chronic ingestion of uranyl nitrate perturbs acetylcholinesterase activity and monoamine metabolism in male rat brain
  74. Bioaccumulation and behavioural effects of depleted uranium in rats exposed to repeated inhalations
  75. Enriched But Not Depleted Uranium Affects Central Nervous System In Long-Term Exposed Rat
  76. Changes in sleep–wake cycle after chronic exposure to uranium in rats
  77. The brain is a target organ after acute exposure to depleted uranium
  78. Effect of U and 137Cs chronic contamination on dopamine and serotonin metabolism in the central nervous system of the rat